From January 1, hospitals will record the antibiotics consumed

From January 1, 2022, health care facilities providing inpatient care will start recording the total consumption of antimicrobial drugs during the year.

Source: https://www.medsprava.com.ua/news/4851-z-1-schnya-statsonari-oblkovuvatimut-spojit-antibotiki

The AWaRe (WHO Model List of Essential Medicines (2019)) classifies antibiotics into three different groups (Access, Watch and Reserve) based on their indications for common infectious syndromes, spectrum of activity and potential for antibiotic resistance. The AWaRe classification is a tool for the management of antibiotics at the local, national and global levels in order to optimize the use of antibiotics and reduce the resistance of pathogens to antibiotics.

The watch group antibiotics are drugs used to treat bacterial infections as first and second line therapy. If you use these drugs excessively and irrationally, antibiotic resistance may occur. In this case, doctors prescribe antibiotics from the reserve group. The reserve group antibiotics are the drugs of last resort. They are intended to treat extremely severe bacterial infections when other antibiotics have failed. Quite often these drugs are more expensive and toxic than first-line drugs therapy. That is why antibiotics of the reserve group should be chosen only at the end.

For example, some of the antibiotics manufactured by Ananta Medicare belong to the following groups: metronidazole is an access group drug; ceftriaxone, ceftazidime, meropenem, imipenem/cilastatin, cefepime are watch group drugs; linezolid is a reserve group drug. Levofloxacin is reserved for the treatment of patients with tuberculosis.